Antidepressants Market to Reach USD $19.92 Billion by 2029 at 2.7% CAGR
The Business Research Company
The Business Research Company's Antidepressants Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, December 9, 2025 /EINPresswire.com/ -- "How Big Is The Antidepressants Market In 2025?
In the past few years, the size of the market for antidepressants has experienced a steady increase. It is projected to rise from $17.33 billion in 2024 to $17.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.3%. The growth witnessed in the historical interval can be ascribed to an increased incidence of mental health disorders, enhanced awareness and less stigma, advancements in diagnostic procedures, increased treatment options, as well as mental health policies and government efforts.
The market size for antidepressants is predicted to exhibit consistent expansion over the forthcoming years, culminating in a total value of $19.92 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. This projected growth during the forecast period can be tied to a surge in mental health consciousness and campaigns, the worldwide influence of stress and modifications in lifestyle, the inclusion of mental health services, advances in psychiatric research, telemedicine, and remote mental health services. Significant trends expected during the forecast period consist of regulatory adjustments, market rivalry, expansion in the generic market, an emphasis on side effect profiles, and emerging markets.
Download a free sample of the antidepressants market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2881&type=smp
What Are The Key Driving Factors For The Growth Of The Antidepressants Market?
Around the world, the increasing instances of mental health problems are the primary reason for the expansion of the antidepressant medication industry, as these drugs are often turned to by patients battling depression, anxiety, and other psychological conditions. Treatments for depression, obsessive-compulsive disorder, childhood bed-wetting, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), and social phobia often involve the use of antidepressants. Depression affects between 2% and 6% of the global population, with elderly individuals being more susceptible than other demographics. As per the World Health Organization, approximately 280 million individuals worldwide were reportedly suffering from depression in 2023. Hence, the escalating mental health disorders are expected to propel the growth of the antidepressant drug market.
Who Are The Key Players In The Antidepressants Industry?
Major players in the Antidepressants include:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• Sanofi S.A.
• Bristol Myers Squibb Company
• Fresenius Kabi AG
• Abbott Laboratories
What Are The Upcoming Trends Of Antidepressants Market In The Globe?
A key trend in the antidepressant market revolves around the treatment of resistant depression. The new remedy making waves is Ketamine, which is typically employed as an anesthetic during surgeries. This drug stimulates the growth of glutamate, in turn triggering the brain to forge fresh neural connections. It not only makes the brain more flexible and capable of creating new routes, but it also aids in the generation of more positive thoughts and behaviors. For example, the Food and Drug Administration (FDA) has given the green light to a new ketamine-based depression remedy known as esketamine, which constitutes half of the ketamine compound. This medicine needs to be delivered as a nasal spray with the patient concurrently taking another antidepressant. Furthermore, its prescription is exclusive to those patients who have tried, but failed, with two other antidepressants.
What Segments Are Covered In The Antidepressants Market Report?
The antidepressants market covered in this report is segmented –
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder
Subsegments:
1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram
2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine
3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin
4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid
View the full antidepressants market report:
https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report
Which Region Is Expected To Lead The Antidepressants Market By 2025?
In 2024, the antidepressants market was dominated by North America, while the Middle East is projected to experience the most significant growth in the coming period. The report investigating the global antidepressants market includes regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Reports Similar to the Global Antidepressants Market 2025, By The Business Research Company
Drugs For Immunotherapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Metabolic Disorders Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Musculoskeletal Disorder Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
